Global Veterinary Needle-free Intradermal Vaccination Market Growth (Status and Outlook) 2025-2031
Description
The global Veterinary Needle-free Intradermal Vaccination market size is predicted to grow from US$ 78.6 million in 2025 to US$ 124 million in 2031; it is expected to grow at a CAGR of 7.9% from 2025 to 2031.
Veterinary needle-free intradermal vaccination is a method of administering vaccines to animals without using a needle. Instead, it uses a specialized device to inject the vaccine into the skin’s dermal layer, where it can trigger an immune response. This technique is considered less invasive, reduces stress for animals, and eliminates the risk of needle-related injuries or contamination. It also improves the precision of vaccine delivery, making it a promising alternative to traditional injection methods, particularly in large-scale animal vaccination programs.
United States market for Veterinary Needle-free Intradermal Vaccination is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Veterinary Needle-free Intradermal Vaccination is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Veterinary Needle-free Intradermal Vaccination is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Veterinary Needle-free Intradermal Vaccination players cover Henke Sass Wolf, HIPRA, Merck, Pulse NeedleFree Systems, AcuShot, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Veterinary Needle-free Intradermal Vaccination Industry Forecast” looks at past sales and reviews total world Veterinary Needle-free Intradermal Vaccination sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Needle-free Intradermal Vaccination sales for 2025 through 2031. With Veterinary Needle-free Intradermal Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Needle-free Intradermal Vaccination industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Needle-free Intradermal Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Veterinary Needle-free Intradermal Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Needle-free Intradermal Vaccination market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Needle-free Intradermal Vaccination and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Needle-free Intradermal Vaccination.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Needle-free Intradermal Vaccination market by product type, application, key players and key regions and countries.
Segmentation by Type:
Pen-type
Gun-type
Segmentation by Application:
Pets and Small Animals
Large Animals
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Henke Sass Wolf
HIPRA
Merck
Pulse NeedleFree Systems
AcuShot
NuGen Medical
Shine Moon
Jiangsu Leju Pharmaceutical Technology
Please note: The report will take approximately 2 business days to prepare and deliver.
Veterinary needle-free intradermal vaccination is a method of administering vaccines to animals without using a needle. Instead, it uses a specialized device to inject the vaccine into the skin’s dermal layer, where it can trigger an immune response. This technique is considered less invasive, reduces stress for animals, and eliminates the risk of needle-related injuries or contamination. It also improves the precision of vaccine delivery, making it a promising alternative to traditional injection methods, particularly in large-scale animal vaccination programs.
United States market for Veterinary Needle-free Intradermal Vaccination is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Veterinary Needle-free Intradermal Vaccination is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Veterinary Needle-free Intradermal Vaccination is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Veterinary Needle-free Intradermal Vaccination players cover Henke Sass Wolf, HIPRA, Merck, Pulse NeedleFree Systems, AcuShot, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Veterinary Needle-free Intradermal Vaccination Industry Forecast” looks at past sales and reviews total world Veterinary Needle-free Intradermal Vaccination sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Needle-free Intradermal Vaccination sales for 2025 through 2031. With Veterinary Needle-free Intradermal Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Needle-free Intradermal Vaccination industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Needle-free Intradermal Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Veterinary Needle-free Intradermal Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Needle-free Intradermal Vaccination market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Needle-free Intradermal Vaccination and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Needle-free Intradermal Vaccination.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Needle-free Intradermal Vaccination market by product type, application, key players and key regions and countries.
Segmentation by Type:
Pen-type
Gun-type
Segmentation by Application:
Pets and Small Animals
Large Animals
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Henke Sass Wolf
HIPRA
Merck
Pulse NeedleFree Systems
AcuShot
NuGen Medical
Shine Moon
Jiangsu Leju Pharmaceutical Technology
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
86 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Veterinary Needle-free Intradermal Vaccination Market Size by Player
- 4 Veterinary Needle-free Intradermal Vaccination by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Veterinary Needle-free Intradermal Vaccination Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
